Efficient siRNA delivery into tumor cells by p19-YSA fusion protein

Molecular Pharmaceutics

Volumn 10, Issue 2, 2013, Pages 763-773

  Choi, Kyung Mi ^a   Park, Ggon Lip ^a   Hwang, Kwang Yeon ^b   Lee, Jeong Won ^c   Ahn, Hyung Jun ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea University   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

cytoplasmic delivery; ephrin mimetic peptide; recombinant protein; siRNA; tumor targeting

Indexed keywords

EPHRIN RECEPTOR A2; HYBRID PROTEIN; P19 YSA FUSION PROTEIN; POLYANION; RIBONUCLEASE; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG BINDING; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG STABILITY; DRUG TARGETING; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONVIRAL GENE DELIVERY SYSTEM; PH; POLYMERIZATION; PRIORITY JOURNAL; STATIC ELECTRICITY;

CELL LINE; HUMANS; PROTEIN STRUCTURE, SECONDARY; RECEPTOR, EPHA2; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING;

EID: 84873363217     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300344p     Document Type: Article

References (47)

1. de Fougerolles, A.; Vornlocher, H. P.; Maraganore, J.; Lieberman, J. Interfering with disease: a progress report on siRNA-based therapeutics Nat. Rev. Drug Discovery 2007, 6, 443-453 (Pubitemid 47064567)
2. Kim, D. H.; Rossi, J. J. Strategies for silencing human disease using RNA interference Nat. Rev. Genet. 2007, 8, 173-184
3. Bumcrot, D.; Manoharan, M.; Koteliansky, V.; Sah, D. W. RNAi therapeutics: a potential new class of pharmaceutical drugs Nat. Chem. Biol. 2006, 2, 711-719 (Pubitemid 44764213)
4. Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discovery 2009, 8, 129-138
5. Lu, P. Y.; Xie, F.; Woodle, M. C. In vivo Application of RNA Interference: from Functional genomics to Therapeutics Adv. Genet. 2005, 54, 117-142
6. Oishi, M.; Nagasaki, Y.; Itaka, K.; Nishiyama, N.; Kataoka, K. Lactosylated Poly(ethylene glycol)-siRNA Conjugate through Acid-Labile Beta-Thiopropionate linkage to construct pH-Sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells J. Am. Chem. Soc. 2005, 127, 1624-1625 (Pubitemid 40229133)
7. Chiu, Y. L.; Rana, T. M. siRNA function in RNAi: a chemical modification analysis RNA 2003, 9, 1034-1048 (Pubitemid 37093614)
8. Czauderna, F.; Fechtner, M.; Dames, S.; Aygun, H.; Klippel, A.; Pronk, G. J.; Giese, K.; Kaufmann, J. Structural variations and stabilising modifications of synthetic siRNAs in mammalian Cells Nucleic Acids Res. 2003, 31, 2705-2716 (Pubitemid 37442115)
9. Hall, A. H.; Wan, J.; Shaughnessy, E. E.; Ramsay Shaw, B.; Alexander, K. A. RNA interference using boranophosphate siRNAs: structure-activity relationships Nucleic Acids Res. 2004, 32, 5991-6000 (Pubitemid 40073994)
10. Shim, M. S.; Kwon, Y. J. Efficient and targeted delivery of siRNA In Vivo FEBS J. 2010, 277, 4814-4827
11. Layzer, J. M.; McCaffrey, A. P.; Tanner, A. K.; Huang, Z.; Kay, M. A.; Sullenger, B. A. In Vivo activity of nuclease-Resistant siRNAs RNA 2004, 10, 766-771 (Pubitemid 38529739)
12. Zhang, S.; Zhao, B.; Jiang, H.; Wang, B.; Ma, B. Cationic lipids and polymers mediated vectors for delivery of siRNA J. Controlled Release 2007, 123, 1-10 (Pubitemid 47444388)
13. Tan, P. H.; Yang, L. C.; Shih, H. C.; Lan, K. C.; Cheng, J. T. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B Subunit reduces formalin-induced nociception in the rat Gene Ther. 2005, 12, 59-66
14. Thomas, M.; Lu, J. J.; Ge, Q.; Zhang, C.; Chen, J.; Klibanov, A. M. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 5679-5684 (Pubitemid 40559619)
15. Watanabe, K.; Harada-shiba, M.; Suzuki, A.; Gokuden, R.; Kurihara, R.; Sugao, Y.; Mori, T.; Katayama, Y.; Niidome, T. In vivo siRNA delivery with dendritic Poly(L-lysine) for the treatment of hypercholesterolemia Mol. BioSyst. 2009, 5, 1306-1310
16. Vangasseri, D. P.; Han, S. J.; Huang, L. Lipid-protamine-DNA-mediated antigen delivery Curr. Drug Delivery 2005, 2, 401-406 (Pubitemid 41277772)
17. Choi, Y. S.; Lee, J. Y.; Suh, J. S.; Kwon, Y. M.; Lee, S. J.; Chung, J. K.; Lee, D. S.; Yang, V. C.; Chung, C. P.; Park, Y. J. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine Biomaterials 2010, 31, 1429-1443
18. Akhtar, S.; Benter, I. F. Nonviral delivery of synthetic siRNAs in vivo J. Clin. Invest. 2007, 117, 3623-3632 (Pubitemid 350224068)
19. Park, T. G.; Jeong, J. H.; Kim, S. W. Current status of polymeric gene delivery systems Adv. Drug Delivery Rev. 2006, 58, 467-486 (Pubitemid 43949425)
20. Moghimi, S. M.; Symonds, P.; Murray, J. C.; Hunter, A. C.; Debska, G.; Szewczyk, A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy Mol. Ther. 2005, 11, 990-995 (Pubitemid 40724119)
21. Symonds, P.; Murray, J. C.; Hunter, A. C.; Debska, G.; Szewczyk, A.; Moghini, S. M. Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis differently FEBS Lett. 2005, 579, 6191-6198 (Pubitemid 41546267)
22. Kim, W. J.; Christensen, L. V.; Jo, S.; Yockman, J. W.; Jeong, J. H.; Kim, Y. H.; Kim, S. W. Inhibition of tumor growth with cholesteryl- oligoarginine/SiRNA targeting VEGF Mol. Ther. 2006, 14, 343-350
23. Kim, S. I.; Shin, D.; Choi, T. H.; Lee, J. C.; Cheon, G. J.; Kim, K. Y.; Park, M.; Kim, M. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I Mol. Ther. 2007, 15, 1145-1152 (Pubitemid 46813617)
24. Song, E.; Zhu, P.; Lee, S. K.; Chowdhury, D.; Kussman, S.; Dykxhoorn, D. M.; Feng, Y.; Palliser, D.; Weiner, D. B.; Shankar, P.; Marasco, W. A.; Lieberman, J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 2005, 23, 709-717 (Pubitemid 41716361)
25. Kumar, P.; Ban, H. S.; Kim, S. S.; Wu, H.; Pearson, T.; Greiner, D. L.; Laouar, A.; Yao, J.; Haridas, V.; Habiro, K.; Yang, Y. G.; Jeong, J. H.; Lee, K. Y.; Kim, Y. H.; Kim, S. W.; Peipp, M.; Fey, G. H.; Mamjunath, N.; Shultz, L. D.; Lee, S. K.; Shankar, P. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice Cell 2008, 134, 577-586
26. Eguchi, A.; Meade, B. R.; Chang, Y. C.; Fredrickson, C. T.; Willert, K.; Puri, N.; Dowdy, S. F. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein Nat. Biotechnol. 2009, 27, 567-571
27. Vargason, J. M.; Szittya, G.; Burgyan, J.; Hall, T. M. Size selective recognition of siRNA by an RNA Silencing suppressor Cell 2003, 115, 799-811 (Pubitemid 38058493)
28. Khuri, F. R.; Nemunaitis, J.; Ganly, I.; Arseneau, J.; Tannock, I. F.; Romel, L.; Gore, M.; Ironside, J.; MacDougall, R. H.; Heise, C.; Randlev, B.; Gillenwater, A. M.; Bruso, P.; Kaye, S. B.; Hong, W. K.; Kirn, D. H. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Nat. Med. 2000, 6, 879-885 (Pubitemid 30644745)
29. Menei, P.; Venier, M. C.; Gamelin, E.; Saint-André, J. P.; Hayek, G.; Jadaud, E.; Fournier, D.; Mercier, P.; Guy, G.; Benoit, J. P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study Cancer 1999, 59, 325-330 (Pubitemid 29327590)
30. Koolpe, M.; Dail, M.; Pasquale, E. B. An ephrin mimetic peptide that selectively targets the EphA2 receptor J. Biol. Chem. 2002, 227, 46974-46979 (Pubitemid 36159202)
31. Scarberry, K. E.; Dickerson, E. B.; McDonald, J. F.; Zhang, Z. J. Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells J. Am. Chem. Soc. 2008, 130, 10258-10262
32. Scatchard, G. The attraction of proteins for small molecules and ions Ann. N.Y. Acad. Sci. 1949, 51, 660-672
33. Scaffidi, C.; Fulda, S.; Srinivasan, A.; Friesen, C.; Li, F.; Tomaselli, K. J.; Debatin, K. M.; Krammer, P. H.; Peter, H. E. Two CD95 (APO-1/Fas) signaling pathways EMBO J. 1998, 17, 1675-1687 (Pubitemid 28119121)
34. Van Geer, M. A.; Brevoord, D.; Kuhlmann, K. F.; Bakker, C. T.; Mizuguchi, H.; Wesseling, J. G.; Ten Kate, F. J.; Gouma, D. J.; Oude Elferink, R. P.; Bosma, P. J. A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer Int. J. Oncol. 2010, 36, 233-244
35. Ye, K.; Malinina, L.; Patel, D. J. Recognition of small interfering RNA by a viral suppressor of RNA silencing Nature 2003, 426, 874-878 (Pubitemid 38056877)
36. Bolcato-Bellemin, A. L.; Bonnet, M. E.; Creusat, G.; Erbacher, P.; Behr, J. P. Sticky overhangs enhance siRNA-mediated gene silencing Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 16050-16055 (Pubitemid 350099361)
37. Putnam, D.; Gentry, C. A.; Pack, D. W.; Langer, R. Polymer-based gene delivery with low cytotoxicity by a unique balance of Side-Chain Termini Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1200-1205 (Pubitemid 32121210)
38. Wang, L. H.; Rothberq., K. G.; Anderson, R. G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation J. Cell Biol. 1993, 123, 1107-1117 (Pubitemid 23352421)
39. Lanaze, C.; Schmid, S. L. The emergence of clathrin-independent pinocytic pathways Curr. Opin. Cell. Biol. 1995, 7, 573-580
40. Hewlett, L. J.; Prescott, A. R.; Watts, C. The coated pit and macropinocytic pathways serve distinct endosome populations J. Cell Biol. 1994, 124, 689-703 (Pubitemid 24085779)
41. Zhuang, G.; Hunter, S.; Hwang, Y.; Chen, J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation J. Biol. Chem. 2007, 282, 2683-2694 (Pubitemid 47076792)
42. Yoo, S.; Shin, J.; Park, S. EphA8-ephrinA5 signaling and clathrin-mediated endocytosis is regulated by Tiam-1, a Rac-specific guanine nucleotide exchange factor Mol. Cells 2010, 29, 603-609
43. Pitulescu, M. E.; Adams, R. H. Eph/ephrin molecules-a hub for signaling and endocytosis Genes Dev. 2010, 24, 2480-2492
44. Tandon, M.; Vemula, S. V.; Mittal, S. K. Emerging strategies for EphA2 receptor targeting for cancer therapeutics Expert Opin. Ther. Targets 2011, 15, 31-51
45. Vargason, J. M.; Szittya, G.; Burgyan, J.; Hall, T. M. Size Selective recognition of siRNA by an RNA silencing suppressor Cell 2003, 115, 799-811 (Pubitemid 38058493)
46. Blau, S.; Jubeh, T. T.; Haupt, S. M.; Rubinstein, A. Drug targeting by surface cationization Crit. Rev. Ther. Drug Carrier Syst. 2000, 17, 425-465
47. Choi, K. M.; Choi, S. H.; Jeon, H.; Kim, I. S.; Ahn, H. J. Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA ACS Nano 2011, 5, 8690-8699